388 related articles for article (PubMed ID: 31341411)
1. Molecular heterogeneity in lung cancer: from mechanisms of origin to clinical implications.
Zito Marino F; Bianco R; Accardo M; Ronchi A; Cozzolino I; Morgillo F; Rossi G; Franco R
Int J Med Sci; 2019; 16(7):981-989. PubMed ID: 31341411
[TBL] [Abstract][Full Text] [Related]
2. Exploring the spatiotemporal genetic heterogeneity in metastatic lung adenocarcinoma using a nuclei flow-sorting approach.
Lorber T; Andor N; Dietsche T; Perrina V; Juskevicius D; Pereira K; Greer SU; Krause A; Müller DC; Savic Prince S; Lardinois D; Barrett MT; Ruiz C; Bubendorf L
J Pathol; 2019 Feb; 247(2):199-213. PubMed ID: 30350422
[TBL] [Abstract][Full Text] [Related]
3. Epigenome-Based Precision Medicine in Lung Cancer.
Kim D; Kim DH
Methods Mol Biol; 2018; 1856():57-85. PubMed ID: 30178246
[TBL] [Abstract][Full Text] [Related]
4. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
Pécuchet N; Legras A; Laurent-Puig P; Blons H
Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity in Lung Cancer.
de Sousa VML; Carvalho L
Pathobiology; 2018; 85(1-2):96-107. PubMed ID: 29635240
[TBL] [Abstract][Full Text] [Related]
6. Spatial Intratumor Genomic Heterogeneity within Localized Prostate Cancer Revealed by Single-nucleus Sequencing.
Su F; Zhang W; Zhang D; Zhang Y; Pang C; Huang Y; Wang M; Cui L; He L; Zhang J; Zou L; Zhang J; Li W; Li L; Shao J; Ma J; Xiao F; Liu M
Eur Urol; 2018 Nov; 74(5):551-559. PubMed ID: 29941308
[TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic intratumor heterogeneity impacts prognosis of lung adenocarcinoma.
Hua X; Zhao W; Pesatori AC; Consonni D; Caporaso NE; Zhang T; Zhu B; Wang M; Jones K; Hicks B; Song L; Sampson J; Wedge DC; Shi J; Landi MT
Nat Commun; 2020 May; 11(1):2459. PubMed ID: 32424208
[TBL] [Abstract][Full Text] [Related]
8. Genomic instability in pancreatic adenocarcinoma: a new step towards precision medicine and novel therapeutic approaches.
Sahin IH; Lowery MA; Stadler ZK; Salo-Mullen E; Iacobuzio-Donahue CA; Kelsen DP; O'Reilly EM
Expert Rev Gastroenterol Hepatol; 2016 Aug; 10(8):893-905. PubMed ID: 26881472
[TBL] [Abstract][Full Text] [Related]
9. Beyond tissue biopsy: a diagnostic framework to address tumor heterogeneity in lung cancer.
Voigt W; Manegold C; Pilz L; Wu YL; Müllauer L; Pirker R; Filipits M; Niklinski J; Petruzelka L; Prosch H
Curr Opin Oncol; 2020 Jan; 32(1):68-77. PubMed ID: 31714259
[TBL] [Abstract][Full Text] [Related]
10. Theranostic Interpolation of Genomic Instability in Breast Cancer.
Rasool R; Ullah I; Mubeen B; Alshehri S; Imam SS; Ghoneim MM; Alzarea SI; Al-Abbasi FA; Murtaza BN; Kazmi I; Nadeem MS
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163783
[TBL] [Abstract][Full Text] [Related]
11. Molecular biology of lung cancer: clinical implications.
Larsen JE; Minna JD
Clin Chest Med; 2011 Dec; 32(4):703-40. PubMed ID: 22054881
[TBL] [Abstract][Full Text] [Related]
12. Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches.
Shea M; Costa DB; Rangachari D
Ther Adv Respir Dis; 2016 Apr; 10(2):113-29. PubMed ID: 26620497
[TBL] [Abstract][Full Text] [Related]
13. Using circulating cell-free DNA to monitor personalized cancer therapy.
Oellerich M; Schütz E; Beck J; Kanzow P; Plowman PN; Weiss GJ; Walson PD
Crit Rev Clin Lab Sci; 2017 May; 54(3):205-218. PubMed ID: 28393575
[TBL] [Abstract][Full Text] [Related]
14. Concurrent DNA Copy-Number Alterations and Mutations in Genes Related to Maintenance of Genome Stability in Uninvolved Mammary Glandular Tissue from Breast Cancer Patients.
Ronowicz A; Janaszak-Jasiecka A; Skokowski J; Madanecki P; Bartoszewski R; Bałut M; Seroczyńska B; Kochan K; Bogdan A; Butkus M; Pęksa R; Ratajska M; Kuźniacka A; Wasąg B; Gucwa M; Krzyżanowski M; Jaśkiewicz J; Jankowski Z; Forsberg L; Ochocka JR; Limon J; Crowley MR; Buckley PG; Messiaen L; Dumanski JP; Piotrowski A
Hum Mutat; 2015 Nov; 36(11):1088-99. PubMed ID: 26219265
[TBL] [Abstract][Full Text] [Related]
15. Role of epigenetics in lung cancer heterogeneity and clinical implication.
Dong N; Shi L; Wang DC; Chen C; Wang X
Semin Cell Dev Biol; 2017 Apr; 64():18-25. PubMed ID: 27575638
[TBL] [Abstract][Full Text] [Related]
16. Genomic variations in plasma cell free DNA differentiate early stage lung cancers from normal controls.
Xia S; Huang CC; Le M; Dittmar R; Du M; Yuan T; Guo Y; Wang Y; Wang X; Tsai S; Suster S; Mackinnon AC; Wang L
Lung Cancer; 2015 Oct; 90(1):78-84. PubMed ID: 26233568
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy and possible applications of genomics in lung cancer.
Alharbi KK
Asian Pac J Cancer Prev; 2015; 16(5):1693-8. PubMed ID: 25773789
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial D310 instability in Chinese lung cancer patients.
Chen XZ; Fang Y; Shi YH; Cui JH; Li LY; Xu YC; Ling B
Mitochondrial DNA A DNA Mapp Seq Anal; 2016; 27(2):1177-80. PubMed ID: 25010070
[TBL] [Abstract][Full Text] [Related]
19. Genomic profiling of esophageal squamous cell carcinoma (ESCC)-Basis for precision medicine.
Yang JW; Choi YL
Pathol Res Pract; 2017 Jul; 213(7):836-841. PubMed ID: 28554745
[TBL] [Abstract][Full Text] [Related]
20. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
